麦克罗利德,林科萨米德和链球蛋白之间的交叉反应:对法国药监数据库的研究
Quentin Le Baron1, Delphine Bourneau-Martin1, Marina Babin1
1Department of Pharmacology-Toxicology and Pharmacovigilance, University Hospital of Angers, Angers, France.
Fundamental & clinical pharmacology
|April 9, 2024
概括
过敏反应 (HSR) 对宏类,林科萨米德和链杆菌素 (MLS) 抗生素可能会发生交叉反应. 对患有MLS HSR的患者来说,过敏学测试至关重要,以指导替代抗生素选择和管理潜在的交叉反应风险.
科学领域:
- 药物监督 药物监督 药物监督
- 临床免疫学临床免疫学
- 传染性疾病 传染性疾病
背景情况:
- 过敏反应 (HSR) 已知用于宏类,林科萨米德和链状蛋白素 (MLS) 抗生素.
- 现有的关于MLS抗生素之间的交叉反应性的数据是有限的,并且往往是矛盾的.
研究的目的:
- 调查MLS抗生素类别内和之间的过敏交叉反应.
- 分析来自法国国家药监数据库 (FPVD) 的HSR到MLS抗生素的数据.
主要方法:
- 在FPVD (1985-2019) 中,对MLS抗生素报告的HSR病例的回顾性分析.
- 包括过敏学测试显示多种MLS抗生素阳性结果的病例.
- 使用标准化的MedDRA查询 (SMQ) 来提取数据.
主要成果:
- 在8394个审查的案件中,有149个符合纳入标准.
- 普里斯胺和螺旋胺是最频繁涉及的MLS抗生素.
- 在62个病例中 (41.6%) 确定了86个MLS之间的交叉反应,其中链条蛋白和MLS类之间的比率更高.
结论:
- 在MLS抗生素之间和之间,交叉反应是显著的可能性.
- 临床医生,特别是皮肤科医生和过敏学家,必须考虑在HSR患者中MLS交叉反应性.
- 在处方替代抗生素之前,建议对MLS进行过敏测试,特别是在严重病例中.
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Cross-reactivity
31.1K
Overview
31.1K


